Amber Siegfried

Doctor of Medicine,  Toronto General - University Health Network 

Location: India

Consulting Services

Hospital-Pharmacy-Insurance Biostatistics Legal Support Research Consulting Admin and Customer Support

Areas Of Interest

Neoplasm, Choroid Obstructions, Renal Artery Mosquito Nets, Treated Dwarfism, Silver Russell Interleukin-8 Transgenes Rehydration Therapy, Oral Shunt, Surgical Arteriovenous Adulteration, Food Patient Monitoring Stamp, Food Diphenylhydantoin Amerind, Central American Gourd, Snake OTX2, Homeobox Protein Hydrogen-Ion Concentration Muscle Caveolin Acute Leukemia, Hybrid Xylaxine grisea, Pyricularia Cortrosyn Thuja plicatas CD49b Antigens Vogt Koyanagi Harada Disease Vertical-Banded Gastroplasty gamma-Trace HTLV-III Serodiagnoses Liposarcoma, Pleomorphic Intravitreal Injections Norovirus Pharmacy Law Non-ketotic Hyperglycinemia Glu Plasminogen RIG-I-like Receptor 1 Packagings, Product NADH Dehydrogenase (Ubiquinone) GI-87084B DNAase

Professional Narrative

Dr. Amber Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Harvard Med 1989
Director Medicine, Mayo Clinic 1994

Education

Director Medicine, Perelman School of Medicine 2006
Doctor of medicine, Yale School of Medicine 1994

Referees


Publications

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :